Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Cash from Operations (2018 - 2025)

Historic Cash from Operations for Qiagen (QGEN) over the last 11 years, with Q4 2025 value amounting to $188.1 million.

  • Qiagen's Cash from Operations fell 3728.93% to $188.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $653.9 million, marking a year-over-year decrease of 1642.76%. This contributed to the annual value of $654.3 million for FY2025, which is 285.43% down from last year.
  • Latest data reveals that Qiagen reported Cash from Operations of $188.1 million as of Q4 2025, which was down 3728.93% from $165.0 million recorded in Q3 2025.
  • Over the past 5 years, Qiagen's Cash from Operations peaked at $300.0 million during Q4 2024, and registered a low of $71.9 million during Q1 2023.
  • Over the past 5 years, Qiagen's median Cash from Operations value was $163.0 million (recorded in 2025), while the average stood at $169.5 million.
  • In the last 5 years, Qiagen's Cash from Operations crashed by 6532.18% in 2023 and then soared by 9819.25% in 2024.
  • Qiagen's Cash from Operations (Quarter) stood at $285.0 million in 2021, then crashed by 56.38% to $124.3 million in 2022, then grew by 21.76% to $151.4 million in 2023, then skyrocketed by 98.19% to $300.0 million in 2024, then plummeted by 37.29% to $188.1 million in 2025.
  • Its last three reported values are $188.1 million in Q4 2025, $165.0 million for Q3 2025, and $161.0 million during Q2 2025.